These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Hematologic side effects of chloramphenicol and thiamphenicol]. Keiser G; Bolli P; Buchegger U Schweiz Med Wochenschr; 1972 Nov; 102(44):1595-8. PubMed ID: 4645045 [No Abstract] [Full Text] [Related]
43. [Mortal medullary aplasia caused by chloramphenicol. Remarks apropos of a case]. Carbon C; Corcos A; Domart A Sem Hop; 1971 Mar; 47(14):890-2. PubMed ID: 4324369 [No Abstract] [Full Text] [Related]
44. The effect of prolonged drug usage on fetal development. An epidemiological approach. Roberts CJ Adv Exp Med Biol; 1972; 27():457-65. PubMed ID: 4680140 [No Abstract] [Full Text] [Related]
46. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Brodsky E; Biger Y; Zeidan Z; Schneider M Isr J Med Sci; 1989 Jan; 25(1):54. PubMed ID: 2925363 [No Abstract] [Full Text] [Related]
47. [Chloramphenicol and thiamphenicol]. Mariani L Clin Ter; 1978 Aug; 86(3):195-218. PubMed ID: 369769 [No Abstract] [Full Text] [Related]
48. [Methods for studying drug risk during pregnancy]. Autret-Leca E; Jonville-Béra AP; Cissoko H Arch Pediatr; 2000 May; 7 Suppl 2():404s-406s. PubMed ID: 10904789 [No Abstract] [Full Text] [Related]
49. [Screening for congenital abnormalities and drug monitoring]. Beckers RF Arch Belg Med Soc; 1979 Jul; 37(7):423-33. PubMed ID: 543708 [No Abstract] [Full Text] [Related]
50. [Epidemiologic studies of aplastic anemia and drugs]. Aoki K Nihon Rinsho; 1978 Jul; 36(7):2658-65. PubMed ID: 359868 [No Abstract] [Full Text] [Related]
51. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381 [No Abstract] [Full Text] [Related]
52. [Nonsense in therapy and diagnosis within pediatrics]. Stickler GB Monatsschr Kinderheilkd (1902); 1977 May; 125(5):248-52. PubMed ID: 327295 [No Abstract] [Full Text] [Related]
53. Monitoring the adverse reactions to drugs and the discipline of therapeutic auditing. Wade OL Q J Med; 1971 Oct; 40(160):570-1. PubMed ID: 5157414 [No Abstract] [Full Text] [Related]
54. Toxic effects of chloramphenicol. A survey of children treated in general practice. Yodfat Y Isr J Med Sci; 1969; 5(6):1184-7. PubMed ID: 5367443 [No Abstract] [Full Text] [Related]
55. Thalidomide and its sequelae. Emanuel M; Rawlins M; Duff G; Breckenridge A Lancet; 2012 Sep; 380(9844):781-3. PubMed ID: 22939670 [No Abstract] [Full Text] [Related]
56. [Iatrogenic hemopathies. Current aspects of drug effects on the formal elements of the blood]. Angela GC; Di Siena F Minerva Med; 1970 Dec; 61(98):5659-76. PubMed ID: 4100810 [No Abstract] [Full Text] [Related]
57. Drug monitoring of surgical patients. Danielson DA; Porter JB; Dinan BJ; O'Connor PC; Lawson DH; Kellaway GS; Jick H JAMA; 1982 Sep; 248(12):1482-5. PubMed ID: 7109170 [TBL] [Abstract][Full Text] [Related]
58. [Pathology of pammyelophthisis following chloramphenicol administration (report of 18 cases)]. Flenker H; Remmele W Beitr Pathol; 1972; 145(1):8-23. PubMed ID: 5014745 [No Abstract] [Full Text] [Related]
59. [Case of drug-induced pancytopenia in a 7-year-old infant]. Wlodarz A Pediatr Pol; 1966 Nov; 41(11):1317-9. PubMed ID: 5981622 [No Abstract] [Full Text] [Related]